DRG uses cookies to improve your experience on this website. Some of the cookies we use are essential for parts of the website to operate. Please be aware that if you continue without changing your cookie settings, you consent to this. For more information on our use of cookies, please review our cookie policy.

DRG and its group companies would like to inform you that we have updated our website privacy policy.

Acknowledge
New look. Same commitment. Decision Resources Group becomes Clarivate. Read more here

 

The days of targeting high-prescribers with drug reps are fading. The evolving healthcare landscape is prompting brands to find new ways to identify and engage physicians, influence treatment journeys, and improve patient access to their medications. And it is increasingly more complicated to find and prioritize the right physician mix.

 

 

Because of this, we see an evolution of relationships between physicians and patients. We also see an evolution in the ways companies can use data, analytics and network science to understand the market and optimize their efforts.

 

Rather than a curated list of prescribers, the new need is to map the relationships between physicians, measure how behaviors flow between physicians and specialists, and understand how much autonomy a physician might have because of a network or hospital affiliation.

 

 

Download the Full Analytics Viewpoint with Case Studies

 

Which levers of influence do you need to consider in today’s landscape?

 

 

All of this is measurable and actionable – with influence scoring.

From here map the network of influence based on your use case —creating priorities and strategy built upon how physicians are connected, how they influence each other, how patients they share flow through their practice, and how prescribing preferences and behaviors are adopted.

 

 

Recommendations for evolving your targeting approach

How can commercial teams start to evolve their approach to physician targeting? Here are a few recommendations to consider:

 

1. Right-size your influence analysis

 

How deep is deep enough? Each layer of discovery creates more questions, but right-size your analysis with these lenses:

  • What are your use cases, and which influence layers map to those objectives?
  • How quickly might you need to pivot your current strategy? What is your team’s ability to react and change?
  • How easily will you be able to activate a new strategy, and get it out to your salesforce? How often can you roll out changes to plans?

 

2. Plan for sales adoption in waves

 

Give field teams a tailored message at every step of commercial adoption – and a narrative that reflects they understand the flow of the patient within the physicians’ network. Keep in mind that the script should evolve as the target list evolves.

 

3. Operationalize your targeting plan

 

Who are you calling on and how frequently? How will you measure progress and success, and how the market continues to evolve.

 

Consider setting up:

  • A dashboard that tracks publications and new influential authors
  • A survey to identify and understand KOLs as identified by their peers
  • Social intelligence to track sentiment and who’s influential now or growing in importance

 

 

Advanced targeting across the lifecycle

 This process isn’t done once. Think of advanced commercial targeting like a muscle, to be strengthened and flexed at all phases of a lifecycle:

 

 

 

Download the Full Analytics Viewpoint with Case Studies

 

Download the full Analytics Viewpoint to see how two teams used advanced commercial targeting to find and prioritize their ideal HCP mix: